Skip to main content
NCBI home page
Gut logoLink to Gut
. 1990 Feb;31(2):198–203. doi: 10.1136/gut.31.2.198

Lactulose inhibits endotoxin induced tumour necrosis factor production by monocytes. An in vitro study.

J W Greve 1, D J Gouma 1, P A von Leeuwen 1, W A Buurman 1
PMCID: PMC1378380  PMID: 2311978

Abstract

Preoperative oral treatment with lactulose is used to prevent complications after surgery in patients with obstructive jaundice. The effect is perhaps the result of an inactivation of gut derived endotoxins but the exact mechanism of action is, however, unknown. Tumour necrosis factor is an important mediator of endotoxin toxicity. The cytokine tumour necrosis factor is mainly produced by mononuclear phagocytes. In this study, the effect of lactulose on the endotoxin induced tumour necrosis factor release by monocytes was investigated. The direct effect of lactulose on endotoxin was tested in a chromogenic limulus amoebocyte lysate assay. Polymyxin B a known inactivator of endotoxin was used as control in both experiments. Lactulose has a limited capacity to inactivate endotoxin as measured in the endotoxin assay. In contrast lactulose significantly reduced endotoxin induced tumour necrosis factor production by monocytes. In conclusion lactulose inhibits tumour necrosis factor production by a direct inhibitory effect on monocytes, rather than by inactivation of endotoxin. Because tumour necrosis factor is an important mediator of endotoxin toxicity, this inhibitory effect could explain the beneficial effect of lactulose in obstructive jaundice.

Full text

PDF
198

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey M. E. Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg. 1976 Oct;63(10):774–778. doi: 10.1002/bjs.1800631011. [DOI] [PubMed] [Google Scholar]
  2. Beutler B., Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med. 1987 Feb 12;316(7):379–385. doi: 10.1056/NEJM198702123160705. [DOI] [PubMed] [Google Scholar]
  3. Beutler B., Krochin N., Milsark I. W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 1986 May 23;232(4753):977–980. doi: 10.1126/science.3754653. [DOI] [PubMed] [Google Scholar]
  4. Beutler B., Milsark I. W., Cerami A. C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985 Aug 30;229(4716):869–871. doi: 10.1126/science.3895437. [DOI] [PubMed] [Google Scholar]
  5. Bircher J., Müller J., Guggenheim P., Haemmerli U. P. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet. 1966 Apr 23;1(7443):890–892. doi: 10.1016/s0140-6736(66)91573-x. [DOI] [PubMed] [Google Scholar]
  6. Cahill C. J. Prevention of postoperative renal failure in patients with obstructive jaundice--the role of bile salts. Br J Surg. 1983 Oct;70(10):590–595. doi: 10.1002/bjs.1800701008. [DOI] [PubMed] [Google Scholar]
  7. Corrigan J. J., Jr, Kiernat J. F. Effect of polymyxin B sulfate on endotoxin activity in a gram-negative septicemia model. Pediatr Res. 1979 Jan;13(1):48–51. doi: 10.1203/00006450-197901000-00011. [DOI] [PubMed] [Google Scholar]
  8. Debets J. M., Van der Linden C. J., Dieteren I. E., Leeuwenberg J. F., Buurman W. A. Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J Immunol. 1988 Aug 15;141(4):1197–1201. [PubMed] [Google Scholar]
  9. Delahunty T., Hollander D. A comparison of intestinal permeability between humans and three common laboratory animals. Comp Biochem Physiol A Comp Physiol. 1987;86(3):565–567. doi: 10.1016/0300-9629(87)90542-1. [DOI] [PubMed] [Google Scholar]
  10. Duff G. W., Atkins E. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods. 1982 Aug 13;52(3):333–340. doi: 10.1016/0022-1759(82)90005-9. [DOI] [PubMed] [Google Scholar]
  11. Friberger P., Sörskog L., Nilsson K., Knös M. The use of a quantitative assay in endotoxin testing. Prog Clin Biol Res. 1987;231:149–169. [PubMed] [Google Scholar]
  12. From A. H., Fong J. S., Good R. A. Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs. Infect Immun. 1979 Mar;23(3):660–664. doi: 10.1128/iai.23.3.660-664.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Graziano R. F., Fanger M. W. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J Immunol. 1987 Nov 15;139(10):3536–3541. [PubMed] [Google Scholar]
  14. Huhtanen C. N., Parrish F. W., Hicks K. B. Inhibition of bacteria by lactulose preparations. Appl Environ Microbiol. 1980 Jul;40(1):171–173. doi: 10.1128/aem.40.1.171-173.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ingoldby C. J., McPherson G. A., Blumgart L. H. Endotoxemia in human obstructive jaundice. Effect of polymyxin B. Am J Surg. 1984 Jun;147(6):766–771. doi: 10.1016/0002-9610(84)90197-1. [DOI] [PubMed] [Google Scholar]
  16. Ingoldby C. J. The value of polymixin B in endotoxaemia due to experimental obstructive jaundice and mesenteric ischaemia. Br J Surg. 1980 Aug;67(8):565–567. doi: 10.1002/bjs.1800670812. [DOI] [PubMed] [Google Scholar]
  17. Lehmann V., Freudenberg M. A., Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med. 1987 Mar 1;165(3):657–663. doi: 10.1084/jem.165.3.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Liehr H., Englisch G., Rasenack U. Lactulose--a drug with antiendotoxin effect. Hepatogastroenterology. 1980 Oct;27(5):356–360. [PubMed] [Google Scholar]
  19. Nathavitharana K. A., Lloyd D. R., Raafat F., Brown G. A., McNeish A. S. Urinary mannitol: lactulose excretion ratios and jejunal mucosal structure. Arch Dis Child. 1988 Sep;63(9):1054–1059. doi: 10.1136/adc.63.9.1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nolan J. P., Leibowitz A. I. Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin b--an antiendotoxin. Gastroenterology. 1978 Sep;75(3):445–449. [PubMed] [Google Scholar]
  21. Olofsson P. Application of a quantitative spectrophotometric endotoxin assay on lymph and plasma from the rat. Eur Surg Res. 1986;18(2):112–121. doi: 10.1159/000128513. [DOI] [PubMed] [Google Scholar]
  22. Pain J. A., Bailey M. E. Experimental and clinical study of lactulose in obstructive jaundice. Br J Surg. 1986 Oct;73(10):775–778. doi: 10.1002/bjs.1800731003. [DOI] [PubMed] [Google Scholar]
  23. Pain J. A., Bailey M. E. Measurement of operative plasma endotoxin levels in jaundiced and non-jaundiced patients. Eur Surg Res. 1987;19(4):207–216. doi: 10.1159/000128702. [DOI] [PubMed] [Google Scholar]
  24. Pain J. A., Cahill C. J., Bailey M. E. Perioperative complications in obstructive jaundice: therapeutic considerations. Br J Surg. 1985 Dec;72(12):942–945. doi: 10.1002/bjs.1800721203. [DOI] [PubMed] [Google Scholar]
  25. Spear G. T., Teodorescu M. Enhancement of human MLR by very low concentrations of lipopolysaccharide and blocking of this enhancement by polymyxin B. J Immunol Methods. 1984 Oct 26;73(2):321–327. doi: 10.1016/0022-1759(84)90407-1. [DOI] [PubMed] [Google Scholar]
  26. Tracey K. J., Fong Y., Hesse D. G., Manogue K. R., Lee A. T., Kuo G. C., Lowry S. F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987 Dec 17;330(6149):662–664. doi: 10.1038/330662a0. [DOI] [PubMed] [Google Scholar]
  27. Turner M. W., Boulton P., Shields J. G., Strobel S., Gibson S., Miller H. R., Levinsky R. J. Intestinal hypersensitivity reactions in the rat. I. Uptake of intact protein, permeability to sugars and their correlation with mucosal mast-cell activation. Immunology. 1988 Jan;63(1):119–124. [PMC free article] [PubMed] [Google Scholar]
  28. Vince A. J., Burridge S. M. Ammonia production by intestinal bacteria: the effects of lactose, lactulose and glucose. J Med Microbiol. 1980 May;13(2):177–191. doi: 10.1099/00222615-13-2-177. [DOI] [PubMed] [Google Scholar]
  29. Vince A., Killingley M., Wrong O. M. Effect of lactulose on ammonia production in a fecal incubation system. Gastroenterology. 1978 Mar;74(3):544–549. [PubMed] [Google Scholar]
  30. Wardle E. N., Wright N. A. Endotoxin and acute renal failure associated with obstructive jaundice. Br Med J. 1970 Nov 21;4(5733):472–474. doi: 10.1136/bmj.4.5733.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wilkinson S. P., Moodie H., Stamatakis J. D., Kakkar V. V., Williams R. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br Med J. 1976 Dec 11;2(6049):1415–1418. doi: 10.1136/bmj.2.6049.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ziegler T. R., Smith R. J., O'Dwyer S. T., Demling R. H., Wilmore D. W. Increased intestinal permeability associated with infection in burn patients. Arch Surg. 1988 Nov;123(11):1313–1319. doi: 10.1001/archsurg.1988.01400350027003. [DOI] [PubMed] [Google Scholar]
  33. van Deventer S. J., ten Cate J. W., Tytgat G. N. Intestinal endotoxemia. Clinical significance. Gastroenterology. 1988 Mar;94(3):825–831. doi: 10.1016/0016-5085(88)90261-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES